CohBar (CWBR) Competitors $0.41 0.00 (0.00%) As of 01/23/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends CWBR vs. ADIL, PLRZ, LIPO, KZIA, ONCO, ALLR, ATNF, SNPX, CPHI, and PPBTShould you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Adial Pharmaceuticals (ADIL), Polyrizon (PLRZ), Lipella Pharmaceuticals (LIPO), Kazia Therapeutics (KZIA), Onconetix (ONCO), Allarity Therapeutics (ALLR), 180 Life Sciences (ATNF), Synaptogenix (SNPX), China Pharma (CPHI), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical products" industry. CohBar vs. Adial Pharmaceuticals Polyrizon Lipella Pharmaceuticals Kazia Therapeutics Onconetix Allarity Therapeutics 180 Life Sciences Synaptogenix China Pharma Purple Biotech CohBar (NASDAQ:CWBR) and Adial Pharmaceuticals (NASDAQ:ADIL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership. Which has stronger valuation and earnings, CWBR or ADIL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCohBarN/AN/A-$12.18MN/AN/AAdial PharmaceuticalsN/AN/A-$5.12MN/AN/A Does the media refer more to CWBR or ADIL? In the previous week, Adial Pharmaceuticals had 2 more articles in the media than CohBar. MarketBeat recorded 2 mentions for Adial Pharmaceuticals and 0 mentions for CohBar. Adial Pharmaceuticals' average media sentiment score of 0.40 beat CohBar's score of 0.00 indicating that Adial Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment CohBar Neutral Adial Pharmaceuticals Neutral Does the MarketBeat Community believe in CWBR or ADIL? Adial Pharmaceuticals received 92 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 58.51% of users gave Adial Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCohBarOutperform Votes1872.00% Underperform Votes728.00% Adial PharmaceuticalsOutperform Votes11058.51% Underperform Votes7841.49% Is CWBR or ADIL more profitable? CohBar's return on equity of 0.00% beat Adial Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets CohBarN/A N/A N/A Adial Pharmaceuticals N/A -168.25%-148.46% Do institutionals and insiders hold more shares of CWBR or ADIL? 2.5% of CohBar shares are held by institutional investors. Comparatively, 16.4% of Adial Pharmaceuticals shares are held by institutional investors. 6.5% of CohBar shares are held by company insiders. Comparatively, 5.2% of Adial Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer CWBR or ADIL? Adial Pharmaceuticals has a consensus price target of $8.00, indicating a potential upside of 917.81%. Given Adial Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Adial Pharmaceuticals is more favorable than CohBar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CohBar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Adial Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more risk & volatility, CWBR or ADIL? CohBar has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Adial Pharmaceuticals has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. SummaryAdial Pharmaceuticals beats CohBar on 9 of the 14 factors compared between the two stocks. Get CohBar News Delivered to You Automatically Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CWBR vs. The Competition Export to ExcelMetricCohBarPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19M$7.04B$5.77B$8.99BDividend YieldN/A2.87%4.78%3.85%P/E RatioN/A6.1326.4618.82Price / SalesN/A311.22453.6978.73Price / CashN/A67.8344.0437.47Price / Book0.086.747.634.64Net Income-$12.18M$138.11M$3.18B$245.69M7 Day PerformanceN/A-2.43%-1.91%-2.66%1 Month PerformanceN/A-1.91%-0.19%-2.15%1 Year Performance-53.41%-5.03%16.70%12.90% CohBar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010ADILAdial Pharmaceuticals2.8183 of 5 stars$0.74-5.9%$8.00+979.3%-16.4%$4.75MN/A0.0020PLRZPolyrizonN/A$1.13+0.6%N/AN/A$4.72MN/A0.00N/AGap DownLIPOLipella Pharmaceuticals2.6724 of 5 stars$3.88-3.5%$16.00+312.4%-60.4%$4.70M$450,000.00-0.914Gap DownKZIAKazia Therapeutics3.225 of 5 stars$0.89-5.3%$11.50+1,192.1%-72.1%$4.49M$1.51M0.0012ONCOOnconetix0.5225 of 5 stars$0.54-0.4%N/A-94.4%$4.48M$60,000.000.0012News CoveragePositive NewsALLRAllarity Therapeutics0.561 of 5 stars$0.98-0.2%N/A-99.6%$4.34MN/A0.0010ATNF180 Life SciencesN/A$1.33-2.2%N/A-65.6%$4.23MN/A0.007Analyst ForecastNews CoveragePositive NewsSNPXSynaptogenix1.9617 of 5 stars$3.10+6.9%$14.00+351.6%-55.4%$4.20MN/A0.004Gap UpCPHIChina PharmaN/A$0.22+1.9%N/A-58.1%$4.16M$7.01M0.00250Analyst ForecastNews CoveragePPBTPurple Biotech2.4514 of 5 stars$3.10-2.8%$33.00+964.5%N/A$4.12MN/A-0.3520Gap Down Related Companies and Tools Related Companies Adial Pharmaceuticals Alternatives Polyrizon Alternatives Lipella Pharmaceuticals Alternatives Kazia Therapeutics Alternatives Onconetix Alternatives Allarity Therapeutics Alternatives 180 Life Sciences Alternatives Synaptogenix Alternatives China Pharma Alternatives Purple Biotech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CWBR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CWBR Stock Alerts